Inflammation and cancer: an epidemiological perspective.
about
Persistent exposure to Mycoplasma induces malignant transformation of human prostate cellsInvasive micropapillary carcinomas arising 42 years after augmentation mammoplasty: a case report and literature reviewInnate immunity and inflammation in ageing: a key for understanding age-related diseasesNeutralizing tumor-promoting chronic inflammation: a magic bullet?Associations between dietary inflammatory index and inflammatory markers in the Asklepios StudyAssociation between inflammatory potential of diet and mortality in the Iowa Women's Health studyInflammatory potential of diet and all-cause, cardiovascular, and cancer mortality in National Health and Nutrition Examination Survey III StudyDietary inflammatory index and risk of colorectal cancer in the Iowa Women's Health StudyApplication of the U.S. EPA mode of action Framework for purposes of guiding future research: a case study involving the oral carcinogenicity of hexavalent chromiumAssociation between dietary inflammatory index and inflammatory markers in the HELENA study.Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival ratesInflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (review).No significant independent relationships with cardiometabolic biomarkers were detected in the Observation of Cardiovascular Risk Factors in Luxembourg study populationChemotherapeutic properties of phospho-nonsteroidal anti-inflammatory drugs, a new class of anticancer compounds.Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates.Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic studySynthesis and anti-cancer potential of the positional isomers of NOSH-aspirin (NBS-1120) a dual nitric oxide and hydrogen sulfide releasing hybrid.Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanismsFactors Associated with Multiple Biomarkers of Systemic Inflammation.Invited commentary: circulating inflammation markers and cancer risk--implications for epidemiologic studies.The Basis of OncoimmunologyMacrophages, PPARs, and Cancer.Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein.Aging and inflammation: etiological culprits of cancerThe diverse roles of the TNF axis in cancer progression and metastasis.COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.Synthesis of five- and six-membered cyclic organic peroxides: Key transformations into peroxide ring-retaining products.Inflammatory potential of diet and risk of oral and pharyngeal cancer in a large case-control study from Italy.Cyclooxygenase-2 expression in lymphoma in north-west of iran.Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant MelanomaRole of COX-2/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma
P2860
Q21142770-07BA547C-FB57-4063-BF5B-A5F39B34AEEEQ21245585-FC21A652-2F66-408A-AD18-A8D6E62DD45AQ24814846-62E80E8F-69B5-4FEE-A667-DA733FC2AADFQ26830931-93D3A17A-30AF-42A6-B5BC-A35725BB140DQ28389652-2B3AB8D6-3868-49AD-9509-49191269A8E4Q28395916-F7B03576-2F4D-48DE-AC84-2B949D688693Q28396236-9CB46518-99C8-4966-8FA6-0157C4D723EAQ28397169-D214FC9E-1568-452A-BF28-9B0327EBCF04Q28744112-B4708346-1D21-4E35-B143-2F46A997FE64Q30240045-3F745DBD-3A76-49B5-AAF0-10FC232B47C0Q33595267-C32CD1F0-B9E9-4143-94C8-F43A6F33ED03Q34000619-A7ED8C83-F69A-4EEE-9135-B207205EF2A9Q35085760-95F138B7-0312-414E-BAE8-8371A01648BEQ35624238-F1548EE8-5FD2-4644-87DB-CEADD2CCC394Q35906815-BF91B25B-D08E-4995-9801-3BFB2C306E12Q36104275-0D795207-0DE0-4EED-ABAC-C44BE9BE67D3Q36119481-B8705D7F-85CB-492F-8465-B7C5629C9534Q36439801-6E85CA71-B4A9-442D-8F94-E67F960A2376Q36655802-EF3F11C4-B430-4A40-AE9A-F89DF099E57FQ36661798-12FDE0DE-9C07-46AF-BED0-17B2C6939F0AQ36678851-6E64340E-4833-47CB-B4E2-EE44249BF6B6Q36743885-6B548787-0F9A-4E50-B557-6FF373200AD3Q37229916-9C3601E7-4496-42AB-9643-9D7803259E1EQ37421235-DCBAAEAD-4431-4F37-8CEC-4BA82393E8CFQ37462069-FA3A9E12-0434-415D-AE6F-20447F204787Q37474735-D99836FF-0C21-4904-802F-065D30E7A086Q37663388-B2CA3640-86EC-4B5C-B86F-54501A578BF5Q38181092-C3CD9D74-5FDE-4690-B268-24961F8FFD08Q40274963-9B78806F-6016-4D9F-89C6-DCC987440E16Q41911601-5052077D-77EA-4551-A342-90C393E4AF12Q42548468-FDDED293-4173-4FFF-9147-485145883C05Q58702065-12E39B17-653A-4A4D-8326-8907E826813C
P2860
Inflammation and cancer: an epidemiological perspective.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Inflammation and cancer: an epidemiological perspective.
@ast
Inflammation and cancer: an epidemiological perspective.
@en
type
label
Inflammation and cancer: an epidemiological perspective.
@ast
Inflammation and cancer: an epidemiological perspective.
@en
prefLabel
Inflammation and cancer: an epidemiological perspective.
@ast
Inflammation and cancer: an epidemiological perspective.
@en
P1476
Inflammation and cancer: an epidemiological perspective
@en
P2093
Michael J Thun
Ted Gansler
P304
6-21; discussion 22-8, 49-52, 266-9
P577
2004-01-01T00:00:00Z